Medtronic Plc
NYSE: MDT
$85.10
-$1.11 (-1.3%)
Real Time Data Delayed 15 Min.
MDT Articles
Friday's top analyst upgrades, downgrades and initiations include BP, Caterpillar, Ciena, CME and Campbell Soup.
Published:
Medtronic reported lower but better-than-expected fiscal first-quarter earnings before the markets opened on Thursday.
Published:
Medtronic is scheduled to report its fiscal first-quarter financial results on Thursday after the markets close.
Published:
Last Updated:
24/7 Wall St. has put together a preview Ambarella, Ciena, Medtronic and other major companies reporting their quarterly results this week.
Published:
Last Updated:
A new research report from UBS makes an interesting switch in the Quality Growth At a Reasonable Price (Q-GARP) portfolio.
Published:
Last Updated:
In a new report, UBS made changes in the firm's Equity Focus list and updated other positions.
Published:
Deutsche Bank provided a list of the major companies in the benchmark S&P 500 index that are not based in the United States. We cross-referenced the list with the Merrill Lynch research data base...
Published:
To kick off June, 24/7 Wall St. has put together a preview of some of the larger companies reporting their quarterly results this week. Most of the main movers will be reporting on Tuesday.
Published:
UBS has updated its High Conviction stock picks, which represent the absolute best of the best at the firm, and we looked for the low volatility leaders in the group.
Published:
Tuesday before the markets opened, Medtronic (NYSE: MDT) reported better-than-expected fiscal third-quarter financial results.
Published:
Medical device maker Medtronic is scheduled to report its fiscal third-quarter results Tuesday before the opening bell.
Published:
As the earnings season winds down, 24/7 Wall St. has put together a preview of some of the larger companies reporting in the coming week.
Published:
24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.
Published:
Last Updated:
At this juncture in the year, it may be a good for investors to review portfolios and see if some winners, and even losers, need to be replaced.
Published:
Last Updated:
Oppenheimer has released its list of potential post-election winners in the medical device industry.
Published: